

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 7.93216971 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 7.45914338 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.05759404 |
| 4 | * triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 7.00652198 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.82047988 |
| 6 | L-phenylalanine catabolic process (GO:0006559) | 6.82047988 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.57888589 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 6.57888589 |
| 9 | high-density lipoprotein particle remodeling (GO:0034375) | 6.34869404 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 6.08517581 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 6.00426793 |
| 12 | negative regulation of fibrinolysis (GO:0051918) | 5.72400422 |
| 13 | urea cycle (GO:0000050) | 5.65234642 |
| 14 | urea metabolic process (GO:0019627) | 5.65234642 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.53150998 |
| 16 | * reverse cholesterol transport (GO:0043691) | 5.49058243 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46547270 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 5.44862004 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 5.44862004 |
| 20 | tryptophan catabolic process (GO:0006569) | 5.44862004 |
| 21 | kynurenine metabolic process (GO:0070189) | 5.44188588 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.41871363 |
| 23 | bile acid biosynthetic process (GO:0006699) | 5.35066023 |
| 24 | * phospholipid efflux (GO:0033700) | 5.30924366 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.27207199 |
| 26 | protein carboxylation (GO:0018214) | 5.27207199 |
| 27 | * plasma lipoprotein particle remodeling (GO:0034369) | 5.27145026 |
| 28 | * protein-lipid complex remodeling (GO:0034368) | 5.27145026 |
| 29 | * macromolecular complex remodeling (GO:0034367) | 5.27145026 |
| 30 | drug metabolic process (GO:0017144) | 5.26150178 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.18126841 |
| 32 | tryptophan metabolic process (GO:0006568) | 5.16570975 |
| 33 | * regulation of triglyceride catabolic process (GO:0010896) | 5.13261513 |
| 34 | negative regulation of hemostasis (GO:1900047) | 5.10004963 |
| 35 | negative regulation of blood coagulation (GO:0030195) | 5.10004963 |
| 36 | plasma lipoprotein particle assembly (GO:0034377) | 5.07646958 |
| 37 | regulation of protein activation cascade (GO:2000257) | 5.04096164 |
| 38 | complement activation, alternative pathway (GO:0006957) | 4.94073067 |
| 39 | cysteine metabolic process (GO:0006534) | 4.92644684 |
| 40 | * cholesterol efflux (GO:0033344) | 4.90791224 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 4.88583165 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.83834983 |
| 43 | oxidative demethylation (GO:0070989) | 4.82818556 |
| 44 | * plasma lipoprotein particle clearance (GO:0034381) | 4.74518801 |
| 45 | serine family amino acid catabolic process (GO:0009071) | 4.67268905 |
| 46 | phenylpropanoid metabolic process (GO:0009698) | 4.65688666 |
| 47 | negative regulation of coagulation (GO:0050819) | 4.65585566 |
| 48 | regulation of complement activation (GO:0030449) | 4.65338833 |
| 49 | complement activation (GO:0006956) | 4.63955798 |
| 50 | bile acid metabolic process (GO:0008206) | 4.63089540 |
| 51 | * acylglycerol homeostasis (GO:0055090) | 4.61296101 |
| 52 | * triglyceride homeostasis (GO:0070328) | 4.61296101 |
| 53 | protein-lipid complex assembly (GO:0065005) | 4.58862323 |
| 54 | positive regulation of blood coagulation (GO:0030194) | 4.58156498 |
| 55 | positive regulation of hemostasis (GO:1900048) | 4.58156498 |
| 56 | * negative regulation of cholesterol transport (GO:0032375) | 4.50653415 |
| 57 | * negative regulation of sterol transport (GO:0032372) | 4.50653415 |
| 58 | negative regulation of wound healing (GO:0061045) | 4.49498639 |
| 59 | ethanol metabolic process (GO:0006067) | 4.48073246 |
| 60 | aromatic amino acid family metabolic process (GO:0009072) | 4.43999500 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.42999479 |
| 62 | intestinal cholesterol absorption (GO:0030299) | 4.38362609 |
| 63 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.37021931 |
| 64 | regulation of humoral immune response (GO:0002920) | 4.35851423 |
| 65 | homocysteine metabolic process (GO:0050667) | 4.34722341 |
| 66 | tyrosine metabolic process (GO:0006570) | 4.32883863 |
| 67 | positive regulation of coagulation (GO:0050820) | 4.24712731 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.22898626 |
| 69 | lysine metabolic process (GO:0006553) | 4.22387978 |
| 70 | lysine catabolic process (GO:0006554) | 4.22387978 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 4.17904081 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 4.17086770 |
| 73 | * positive regulation of lipoprotein lipase activity (GO:0051006) | 4.13173685 |
| 74 | * positive regulation of triglyceride lipase activity (GO:0061365) | 4.13173685 |
| 75 | * plasma lipoprotein particle organization (GO:0071827) | 4.12890842 |
| 76 | drug catabolic process (GO:0042737) | 4.11146739 |
| 77 | phospholipid homeostasis (GO:0055091) | 4.09786179 |
| 78 | bile acid and bile salt transport (GO:0015721) | 4.09714244 |
| 79 | * cholesterol homeostasis (GO:0042632) | 4.08800127 |
| 80 | negative regulation of protein activation cascade (GO:2000258) | 4.06674540 |
| 81 | * lipoprotein metabolic process (GO:0042157) | 4.06358198 |
| 82 | glycine metabolic process (GO:0006544) | 4.03581741 |
| 83 | * sterol homeostasis (GO:0055092) | 4.02633652 |
| 84 | cellular glucuronidation (GO:0052695) | 3.98732438 |
| 85 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.98516998 |
| 86 | * positive regulation of lipid catabolic process (GO:0050996) | 3.98357973 |
| 87 | fibrinolysis (GO:0042730) | 3.97798130 |
| 88 | arginine metabolic process (GO:0006525) | 3.96592730 |
| 89 | glutamate metabolic process (GO:0006536) | 3.92253209 |
| 90 | * protein-lipid complex subunit organization (GO:0071825) | 3.89937135 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.88473520 |
| 92 | indolalkylamine metabolic process (GO:0006586) | 3.86194759 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.85551378 |
| 94 | serine family amino acid metabolic process (GO:0009069) | 3.85324827 |
| 95 | blood coagulation, intrinsic pathway (GO:0007597) | 3.85237535 |
| 96 | cellular amino acid catabolic process (GO:0009063) | 3.84626895 |
| 97 | imidazole-containing compound metabolic process (GO:0052803) | 3.83499461 |
| 98 | regulation of apoptotic cell clearance (GO:2000425) | 3.82961390 |
| 99 | flavonoid metabolic process (GO:0009812) | 3.80099127 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.79668401 |
| 101 | cellular biogenic amine catabolic process (GO:0042402) | 3.77736803 |
| 102 | amine catabolic process (GO:0009310) | 3.77736803 |
| 103 | alkaloid metabolic process (GO:0009820) | 3.76313775 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 3.76027763 |
| 105 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.75909617 |
| 106 | benzene-containing compound metabolic process (GO:0042537) | 3.74014502 |
| 107 | coenzyme catabolic process (GO:0009109) | 3.72625134 |
| 108 | S-adenosylmethionine metabolic process (GO:0046500) | 3.72310067 |
| 109 | heme transport (GO:0015886) | 3.69507538 |
| 110 | acute inflammatory response (GO:0002526) | 3.65585927 |
| 111 | ketone body metabolic process (GO:1902224) | 3.64511736 |
| 112 | cytolysis (GO:0019835) | 3.61861041 |
| 113 | acute-phase response (GO:0006953) | 3.60290105 |
| 114 | intestinal absorption (GO:0050892) | 3.60025237 |
| 115 | opsonization (GO:0008228) | 3.59946244 |
| 116 | regulation of cholesterol homeostasis (GO:2000188) | 3.59555314 |
| 117 | protein activation cascade (GO:0072376) | 3.58272553 |
| 118 | cofactor catabolic process (GO:0051187) | 3.57754133 |
| 119 | uronic acid metabolic process (GO:0006063) | 3.56439986 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.56439986 |
| 121 | ethanol oxidation (GO:0006069) | 3.55766532 |
| 122 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55598211 |
| 123 | regulation of plasminogen activation (GO:0010755) | 3.49887789 |
| 124 | complement activation, classical pathway (GO:0006958) | 3.47876792 |
| 125 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.44367407 |
| 126 | proline metabolic process (GO:0006560) | 3.39770124 |
| 127 | hormone catabolic process (GO:0042447) | 3.38178137 |
| 128 | negative regulation of complement activation (GO:0045916) | 3.37928417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.07326531 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.03744400 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77052989 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.32430630 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.00370929 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.99967366 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.90424497 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81575267 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.80885416 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.36050062 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6265884 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91327320 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88957443 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 1.67045545 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58330424 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.58314355 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57493421 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54436610 |
| 19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.48110440 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45746005 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.45619810 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.45104395 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34634593 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20893855 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20596030 |
| 26 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15159284 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11797563 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09402345 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07232614 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06917615 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.03376819 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01322116 |
| 33 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01278810 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93689837 |
| 35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93546956 |
| 36 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92312148 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91079307 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90045936 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89921507 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87119978 |
| 41 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85716957 |
| 42 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84324348 |
| 43 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.82854770 |
| 44 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82546149 |
| 45 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81247573 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.80754047 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.80486484 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.80043097 |
| 49 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79207118 |
| 50 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.78670864 |
| 51 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.78463455 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.78341814 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78111949 |
| 54 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77401812 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.77253471 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.76412374 |
| 57 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75592436 |
| 58 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74647009 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73832711 |
| 60 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73595273 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.72213553 |
| 62 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.71031339 |
| 63 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.70322121 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.69482659 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.69067341 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.68685564 |
| 67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67521702 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.67155363 |
| 69 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.66934454 |
| 70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.66850723 |
| 71 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66053879 |
| 72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65822666 |
| 73 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.65052589 |
| 74 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.64812220 |
| 75 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.64537587 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63681684 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63420594 |
| 78 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.63401261 |
| 79 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.63242896 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.63226110 |
| 81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.62976611 |
| 82 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62747719 |
| 83 | GATA1_19941826_ChIP-Seq_K562_Human | 0.62661133 |
| 84 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62198619 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.61982018 |
| 86 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.61859554 |
| 87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.61777498 |
| 88 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.61759124 |
| 89 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61730056 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61643991 |
| 91 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.60711178 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 0.60507625 |
| 93 | P300_27268052_Chip-Seq_Bcells_Human | 0.60354176 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60196595 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.59832255 |
| 96 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.59770929 |
| 97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.59100939 |
| 98 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.58259900 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57938132 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57938132 |
| 101 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.57832003 |
| 102 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.57434563 |
| 103 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.56406742 |
| 104 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.54922947 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.54486615 |
| 106 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.53133922 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52944703 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52162934 |
| 109 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51925391 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.51658621 |
| 111 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.51644486 |
| 112 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.51101696 |
| 113 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49205500 |
| 114 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.49061638 |
| 115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48213826 |
| 116 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48003158 |
| 117 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47782663 |
| 118 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.47621422 |
| 119 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46096657 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.45882703 |
| 121 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45019283 |
| 122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44984737 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43633327 |
| 124 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.43565405 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43462571 |
| 126 | CBP_21632823_ChIP-Seq_H3396_Human | 0.43115971 |
| 127 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42515831 |
| 128 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.42456066 |
| 129 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.41560078 |
| 130 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.40139868 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.39874285 |
| 132 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.39713882 |
| 133 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.39131369 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.90228201 |
| 2 | MP0005360_urolithiasis | 7.81230981 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.96498495 |
| 4 | MP0005365_abnormal_bile_salt | 5.69544754 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.71262760 |
| 6 | MP0009840_abnormal_foam_cell | 4.16421117 |
| 7 | MP0003252_abnormal_bile_duct | 3.87348553 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.85774426 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.75296998 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.10886461 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.79882981 |
| 12 | MP0005083_abnormal_biliary_tract | 2.76117406 |
| 13 | MP0005332_abnormal_amino_acid | 2.61263673 |
| 14 | MP0003195_calcinosis | 2.44509971 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.27488781 |
| 16 | MP0000609_abnormal_liver_physiology | 2.17487200 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.05943795 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.93434988 |
| 19 | MP0009697_abnormal_copulation | 1.82905609 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.79102889 |
| 21 | MP0001764_abnormal_homeostasis | 1.66459383 |
| 22 | MP0003868_abnormal_feces_composition | 1.61760006 |
| 23 | MP0005451_abnormal_body_composition | 1.54922461 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51474004 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.46366443 |
| 26 | MP0003011_delayed_dark_adaptation | 1.39284742 |
| 27 | MP0000604_amyloidosis | 1.34716194 |
| 28 | MP0002254_reproductive_system_inflammat | 1.29733545 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.28597442 |
| 30 | MP0003186_abnormal_redox_activity | 1.26437599 |
| 31 | MP0009764_decreased_sensitivity_to | 1.21312249 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.18301729 |
| 33 | MP0000598_abnormal_liver_morphology | 1.16699683 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.07291831 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.06667816 |
| 36 | MP0008469_abnormal_protein_level | 1.05598107 |
| 37 | MP0009763_increased_sensitivity_to | 1.05027109 |
| 38 | MP0002132_abnormal_respiratory_system | 0.98865045 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.95104593 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.91516400 |
| 41 | MP0003879_abnormal_hair_cell | 0.91233140 |
| 42 | MP0001915_intracranial_hemorrhage | 0.89061685 |
| 43 | MP0005647_abnormal_sex_gland | 0.89017640 |
| 44 | MP0003436_decreased_susceptibility_to | 0.88424804 |
| 45 | MP0005408_hypopigmentation | 0.85483118 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.85417300 |
| 47 | MP0005464_abnormal_platelet_physiology | 0.85090023 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.79778055 |
| 49 | MP0010368_abnormal_lymphatic_system | 0.78670235 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.76582629 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.74300316 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 0.72363363 |
| 53 | MP0003690_abnormal_glial_cell | 0.71878250 |
| 54 | MP0009053_abnormal_anal_canal | 0.69433386 |
| 55 | MP0005448_abnormal_energy_balance | 0.68348938 |
| 56 | MP0002971_abnormal_brown_adipose | 0.67938714 |
| 57 | MP0003724_increased_susceptibility_to | 0.67335431 |
| 58 | MP0005334_abnormal_fat_pad | 0.67325242 |
| 59 | MP0005266_abnormal_metabolism | 0.64686757 |
| 60 | MP0005535_abnormal_body_temperature | 0.61860318 |
| 61 | MP0004264_abnormal_extraembryonic_tissu | 0.61587046 |
| 62 | MP0003718_maternal_effect | 0.61369613 |
| 63 | MP0002168_other_aberrant_phenotype | 0.61126869 |
| 64 | MP0006082_CNS_inflammation | 0.60521337 |
| 65 | MP0003329_amyloid_beta_deposits | 0.60458082 |
| 66 | MP0001756_abnormal_urination | 0.59866680 |
| 67 | MP0003075_altered_response_to | 0.57896050 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.57557524 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.53471398 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 0.53471398 |
| 71 | MP0005166_decreased_susceptibility_to | 0.53305148 |
| 72 | MP0000685_abnormal_immune_system | 0.53035206 |
| 73 | MP0001845_abnormal_inflammatory_respons | 0.52682593 |
| 74 | MP0005058_abnormal_lysosome_morphology | 0.52409744 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 0.52094382 |
| 76 | MP0005670_abnormal_white_adipose | 0.51846250 |
| 77 | MP0000639_abnormal_adrenal_gland | 0.51440913 |
| 78 | MP0005023_abnormal_wound_healing | 0.51208781 |
| 79 | MP0002822_catalepsy | 0.51150877 |
| 80 | MP0002282_abnormal_trachea_morphology | 0.51101988 |
| 81 | MP0005395_other_phenotype | 0.50575143 |
| 82 | MP0008873_increased_physiological_sensi | 0.50186741 |
| 83 | MP0004130_abnormal_muscle_cell | 0.49546617 |
| 84 | MP0009785_altered_susceptibility_to | 0.49047603 |
| 85 | MP0000858_altered_metastatic_potential | 0.48867648 |
| 86 | MP0003638_abnormal_response/metabolism_ | 0.48531440 |
| 87 | MP0000920_abnormal_myelination | 0.48141274 |
| 88 | MP0002089_abnormal_postnatal_growth/wei | 0.47983998 |
| 89 | MP0004883_abnormal_blood_vessel | 0.46376878 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.46131404 |
| 91 | MP0002419_abnormal_innate_immunity | 0.45056551 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.44276571 |
| 93 | MP0000249_abnormal_blood_vessel | 0.44173900 |
| 94 | MP0006035_abnormal_mitochondrial_morpho | 0.42909863 |
| 95 | MP0001661_extended_life_span | 0.42255450 |
| 96 | MP0003303_peritoneal_inflammation | 0.41916634 |
| 97 | MP0005025_abnormal_response_to | 0.41864661 |
| 98 | MP0004147_increased_porphyrin_level | 0.41770776 |
| 99 | MP0005164_abnormal_response_to | 0.41569924 |
| 100 | MP0002796_impaired_skin_barrier | 0.41011266 |
| 101 | MP0009115_abnormal_fat_cell | 0.40901773 |
| 102 | MP0000343_altered_response_to | 0.40482166 |
| 103 | MP0001853_heart_inflammation | 0.39972785 |
| 104 | MP0004947_skin_inflammation | 0.38118096 |
| 105 | MP0002928_abnormal_bile_duct | 0.37791121 |
| 106 | MP0003953_abnormal_hormone_level | 0.36883193 |
| 107 | MP0008872_abnormal_physiological_respon | 0.36877122 |
| 108 | MP0002249_abnormal_larynx_morphology | 0.35621896 |
| 109 | MP0010234_abnormal_vibrissa_follicle | 0.34372114 |
| 110 | MP0001881_abnormal_mammary_gland | 0.33885687 |
| 111 | MP0008874_decreased_physiological_sensi | 0.33141572 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.33101707 |
| 113 | MP0001243_abnormal_dermal_layer | 0.32934356 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.32642817 |
| 115 | MP0002148_abnormal_hypersensitivity_rea | 0.32284159 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.31970344 |
| 117 | MP0005666_abnormal_adipose_tissue | 0.31871765 |
| 118 | MP0003632_abnormal_nervous_system | 0.31068474 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.30755392 |
| 120 | MP0001986_abnormal_taste_sensitivity | 0.30720309 |
| 121 | MP0003878_abnormal_ear_physiology | 0.29235917 |
| 122 | MP0005377_hearing/vestibular/ear_phenot | 0.29235917 |
| 123 | MP0002090_abnormal_vision | 0.28985312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.08295991 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 6.89199074 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.67258181 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 6.63178730 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30081041 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.28812482 |
| 7 | * Xanthomatosis (HP:0000991) | 5.87723662 |
| 8 | Hypolipoproteinemia (HP:0010981) | 5.19509755 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.17102837 |
| 10 | Complement deficiency (HP:0004431) | 5.03677320 |
| 11 | Joint hemorrhage (HP:0005261) | 4.87871594 |
| 12 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.66473541 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.52842101 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.51866695 |
| 15 | Hyperammonemia (HP:0001987) | 4.41377249 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.39684258 |
| 17 | Epidermoid cyst (HP:0200040) | 4.32868562 |
| 18 | Fat malabsorption (HP:0002630) | 4.14332201 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.00206428 |
| 20 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95831765 |
| 21 | Hyperglycinemia (HP:0002154) | 3.94640460 |
| 22 | Hyperglycinuria (HP:0003108) | 3.92956515 |
| 23 | Hypoglycemic coma (HP:0001325) | 3.92577226 |
| 24 | Ketosis (HP:0001946) | 3.89403013 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.82670537 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.79893624 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.78983478 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.78983478 |
| 29 | Abnormality of complement system (HP:0005339) | 3.78274425 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76955887 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.73133296 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.59922599 |
| 33 | Acanthocytosis (HP:0001927) | 3.40594396 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.32059257 |
| 35 | Purpura (HP:0000979) | 3.30451039 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24811198 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21705499 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 3.16848814 |
| 39 | Spontaneous abortion (HP:0005268) | 3.11228663 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.04251194 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.92315910 |
| 42 | Myocardial infarction (HP:0001658) | 2.84438654 |
| 43 | Hypochromic microcytic anemia (HP:0004840) | 2.84031907 |
| 44 | Steatorrhea (HP:0002570) | 2.82400801 |
| 45 | Glomerulonephritis (HP:0000099) | 2.81450058 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79894766 |
| 47 | Metabolic acidosis (HP:0001942) | 2.77653607 |
| 48 | Ketoacidosis (HP:0001993) | 2.75928493 |
| 49 | Amyloidosis (HP:0011034) | 2.75594309 |
| 50 | Abnormality of serum amino acid levels (HP:0003112) | 2.72539460 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.69810144 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.67872721 |
| 53 | Skin nodule (HP:0200036) | 2.65395191 |
| 54 | Malnutrition (HP:0004395) | 2.64582176 |
| 55 | Poikilocytosis (HP:0004447) | 2.61442865 |
| 56 | Hypoglycemic seizures (HP:0002173) | 2.56159092 |
| 57 | Pulmonary embolism (HP:0002204) | 2.55499254 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.52896793 |
| 59 | Cholecystitis (HP:0001082) | 2.52896793 |
| 60 | Gingival bleeding (HP:0000225) | 2.50536983 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46999693 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.46999693 |
| 63 | Vascular calcification (HP:0004934) | 2.45324190 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.44945363 |
| 65 | Cholelithiasis (HP:0001081) | 2.44205732 |
| 66 | Lethargy (HP:0001254) | 2.42099114 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.34907795 |
| 68 | Abnormality of proline metabolism (HP:0010907) | 2.33612541 |
| 69 | Hydroxyprolinuria (HP:0003080) | 2.33612541 |
| 70 | Esophageal varix (HP:0002040) | 2.27199806 |
| 71 | Irritability (HP:0000737) | 2.27075489 |
| 72 | Menorrhagia (HP:0000132) | 2.25323440 |
| 73 | Spastic diplegia (HP:0001264) | 2.24855509 |
| 74 | Mitral stenosis (HP:0001718) | 2.19108658 |
| 75 | Cerebral edema (HP:0002181) | 2.18286309 |
| 76 | Thrombophlebitis (HP:0004418) | 2.16439292 |
| 77 | Gout (HP:0001997) | 2.16054578 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.15761838 |
| 79 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15425720 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.15041695 |
| 81 | Increased serum ferritin (HP:0003281) | 2.14257936 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 2.12521811 |
| 83 | Late onset (HP:0003584) | 2.12379402 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.10740072 |
| 85 | Osteomalacia (HP:0002749) | 2.09255562 |
| 86 | Hypophosphatemic rickets (HP:0004912) | 2.08968781 |
| 87 | Reticulocytosis (HP:0001923) | 2.05129730 |
| 88 | Nausea (HP:0002018) | 2.05119097 |
| 89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04813816 |
| 90 | Nephritis (HP:0000123) | 2.03565036 |
| 91 | Reduced antithrombin III activity (HP:0001976) | 2.03107738 |
| 92 | Vomiting (HP:0002013) | 2.02846527 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.02630557 |
| 94 | Fair hair (HP:0002286) | 2.01715223 |
| 95 | Gangrene (HP:0100758) | 2.00426346 |
| 96 | Neonatal onset (HP:0003623) | 1.99693440 |
| 97 | * Pancreatitis (HP:0001733) | 1.98925600 |
| 98 | Abnormality of the gallbladder (HP:0005264) | 1.97721304 |
| 99 | Retinal atrophy (HP:0001105) | 1.97093194 |
| 100 | Glycosuria (HP:0003076) | 1.94419509 |
| 101 | Abnormality of urine glucose concentration (HP:0011016) | 1.94419509 |
| 102 | Arthropathy (HP:0003040) | 1.92959895 |
| 103 | Epistaxis (HP:0000421) | 1.92795037 |
| 104 | Enlarged kidneys (HP:0000105) | 1.92739078 |
| 105 | Opisthotonus (HP:0002179) | 1.90832882 |
| 106 | Brushfield spots (HP:0001088) | 1.89367790 |
| 107 | Abnormal platelet function (HP:0011869) | 1.85314861 |
| 108 | Impaired platelet aggregation (HP:0003540) | 1.85314861 |
| 109 | Rickets (HP:0002748) | 1.84677095 |
| 110 | Mucopolysacchariduria (HP:0008155) | 1.84561706 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84561706 |
| 112 | Proximal tubulopathy (HP:0000114) | 1.84399413 |
| 113 | Elevated alkaline phosphatase (HP:0003155) | 1.83510287 |
| 114 | Confusion (HP:0001289) | 1.83222484 |
| 115 | Abnormality of vitamin metabolism (HP:0100508) | 1.82933792 |
| 116 | Abnormal cartilage morphology (HP:0002763) | 1.82814268 |
| 117 | Ileus (HP:0002595) | 1.82510726 |
| 118 | Neonatal hypoglycemia (HP:0001998) | 1.81003599 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77843609 |
| 120 | Joint swelling (HP:0001386) | 1.77601852 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77224196 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77224196 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77224196 |
| 124 | Hyperphosphaturia (HP:0003109) | 1.76649806 |
| 125 | Bifid scrotum (HP:0000048) | 1.73626188 |
| 126 | Hypophosphatemia (HP:0002148) | 1.73172434 |
| 127 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.72941089 |
| 128 | Pathologic fracture (HP:0002756) | 1.50495248 |
| 129 | Abnormal urine phosphate concentration (HP:0012599) | 1.50006088 |
| 130 | Increased mean platelet volume (HP:0011877) | 1.49567217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.23234469 |
| 2 | ERN1 | 4.70282878 |
| 3 | FGFR4 | 4.02427488 |
| 4 | SIK1 | 3.58114523 |
| 5 | MST1R | 3.10100212 |
| 6 | TAOK3 | 2.89821244 |
| 7 | INSRR | 2.39965166 |
| 8 | FRK | 2.39623897 |
| 9 | ERBB4 | 2.33306826 |
| 10 | TYK2 | 2.21067156 |
| 11 | GRK6 | 2.01143364 |
| 12 | ICK | 1.89892115 |
| 13 | PKN2 | 1.81416865 |
| 14 | MAPK11 | 1.78569787 |
| 15 | PTK6 | 1.75706061 |
| 16 | FLT3 | 1.74456568 |
| 17 | MAP2K4 | 1.73120991 |
| 18 | TBK1 | 1.68957875 |
| 19 | PIK3CG | 1.68451005 |
| 20 | MAP3K14 | 1.64426005 |
| 21 | IRAK3 | 1.62312739 |
| 22 | PBK | 1.61066295 |
| 23 | NEK9 | 1.56752678 |
| 24 | ABL2 | 1.55868980 |
| 25 | TRIB3 | 1.53807455 |
| 26 | CAMKK2 | 1.45686760 |
| 27 | LATS1 | 1.36025516 |
| 28 | MAP3K11 | 1.31009460 |
| 29 | KDR | 1.30513414 |
| 30 | DAPK2 | 1.28734952 |
| 31 | MAP3K10 | 1.27299574 |
| 32 | JAK2 | 1.27151846 |
| 33 | PIK3CA | 1.26282543 |
| 34 | MET | 1.20421353 |
| 35 | PRPF4B | 1.20144570 |
| 36 | EPHB1 | 1.18842054 |
| 37 | MAP2K3 | 1.18532421 |
| 38 | JAK1 | 1.17587060 |
| 39 | RIPK1 | 1.16067538 |
| 40 | MAP3K3 | 1.15875670 |
| 41 | CAMK1G | 1.02079919 |
| 42 | PRKCG | 1.00795596 |
| 43 | PRKAA2 | 1.00097680 |
| 44 | TNK2 | 0.98691802 |
| 45 | WNK4 | 0.97503755 |
| 46 | BLK | 0.96057931 |
| 47 | PINK1 | 0.95912109 |
| 48 | IKBKE | 0.95619185 |
| 49 | CSK | 0.95393115 |
| 50 | ERBB2 | 0.95225125 |
| 51 | NME2 | 0.95019775 |
| 52 | MAP3K7 | 0.92180890 |
| 53 | RIPK4 | 0.92063466 |
| 54 | CDK6 | 0.87384091 |
| 55 | MAPK4 | 0.84094877 |
| 56 | PDK2 | 0.84005525 |
| 57 | PRKCZ | 0.79486266 |
| 58 | CAMKK1 | 0.76655554 |
| 59 | MAP4K1 | 0.76438021 |
| 60 | MATK | 0.75923125 |
| 61 | DYRK1B | 0.75573472 |
| 62 | NTRK3 | 0.75213630 |
| 63 | PRKACG | 0.72321970 |
| 64 | BMX | 0.70230568 |
| 65 | MAP2K2 | 0.69150987 |
| 66 | EPHA3 | 0.68426622 |
| 67 | PTK2 | 0.67077971 |
| 68 | TXK | 0.66588929 |
| 69 | SYK | 0.66482045 |
| 70 | MAP2K6 | 0.66213864 |
| 71 | PDPK1 | 0.64026594 |
| 72 | MAP3K2 | 0.63189777 |
| 73 | GSK3A | 0.61354335 |
| 74 | PRKG1 | 0.61006904 |
| 75 | RET | 0.60679768 |
| 76 | FGFR2 | 0.60498441 |
| 77 | PIM2 | 0.59151850 |
| 78 | MAPK12 | 0.59065091 |
| 79 | CSF1R | 0.57446314 |
| 80 | STK38L | 0.57374847 |
| 81 | GRK7 | 0.56627919 |
| 82 | MAP3K5 | 0.55977151 |
| 83 | TGFBR2 | 0.55741001 |
| 84 | PRKG2 | 0.55481921 |
| 85 | CAMK1D | 0.55382829 |
| 86 | CDC42BPA | 0.54951687 |
| 87 | MAPKAPK3 | 0.54924231 |
| 88 | GRK1 | 0.54706485 |
| 89 | DDR2 | 0.54419206 |
| 90 | CAMK2G | 0.54315444 |
| 91 | EPHA2 | 0.53400035 |
| 92 | TAOK2 | 0.52742269 |
| 93 | PRKCQ | 0.51853788 |
| 94 | TESK2 | 0.50844476 |
| 95 | LCK | 0.50148476 |
| 96 | PRKACA | 0.49577392 |
| 97 | CAMK4 | 0.47974180 |
| 98 | MAP3K13 | 0.47896883 |
| 99 | ACVR1B | 0.47781626 |
| 100 | SIK2 | 0.46984671 |
| 101 | FGR | 0.46633870 |
| 102 | ARAF | 0.46286237 |
| 103 | FGFR3 | 0.45591168 |
| 104 | MAP3K1 | 0.45549033 |
| 105 | PDGFRA | 0.45364289 |
| 106 | MAP2K1 | 0.44957070 |
| 107 | SGK1 | 0.44487728 |
| 108 | PRKAA1 | 0.44089528 |
| 109 | SRC | 0.43462739 |
| 110 | CDK4 | 0.43413025 |
| 111 | CSNK1D | 0.43052236 |
| 112 | PDK1 | 0.41719002 |
| 113 | NUAK1 | 0.41718580 |
| 114 | TIE1 | 0.40734191 |
| 115 | IKBKB | 0.40707467 |
| 116 | SMG1 | 0.40495881 |
| 117 | FES | 0.40437817 |
| 118 | KSR2 | 0.39354388 |
| 119 | IGF1R | 0.38401665 |
| 120 | EGFR | 0.38218277 |
| 121 | CSNK2A1 | 0.35626061 |
| 122 | RPS6KA3 | 0.35138765 |
| 123 | AKT3 | 0.34778538 |
| 124 | ZAP70 | 0.34406198 |
| 125 | PRKCB | 0.34071844 |
| 126 | MAPK7 | 0.33532225 |
| 127 | STK10 | 0.33213514 |
| 128 | LYN | 0.32098999 |
| 129 | CHUK | 0.31990586 |
| 130 | SGK3 | 0.31136271 |
| 131 | PRKCD | 0.29354522 |
| 132 | STK3 | 0.28817281 |
| 133 | JAK3 | 0.28708157 |
| 134 | ABL1 | 0.28328190 |
| 135 | KIT | 0.27904173 |
| 136 | PRKCA | 0.27861371 |
| 137 | MAPK15 | 0.26991929 |
| 138 | PIM1 | 0.26868243 |
| 139 | IRAK4 | 0.26318704 |
| 140 | IRAK2 | 0.25159922 |
| 141 | MAP3K6 | 0.24654317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17715388 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.50249245 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31065222 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.13310677 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07611640 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82089855 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58476755 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58149670 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.54231593 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50606925 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43622934 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23650564 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22600317 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08560159 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.01454588 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01280815 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00184720 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99657925 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.96768554 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.96723270 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85714447 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84376776 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77973655 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75753938 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75082650 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72438740 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68683438 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.67743895 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62152945 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59421655 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55219670 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53195814 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.51662287 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49735561 |
| 35 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.48706487 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48198113 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46459149 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.44970534 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.44185061 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38228729 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31994006 |
| 42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30884188 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30222559 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29198110 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19879649 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.19839013 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19639460 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17049659 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.15952381 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14501099 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11293081 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08866205 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07784858 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04537466 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03270792 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96656155 |
| 57 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92551266 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87389056 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87137903 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84771653 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79507248 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79451935 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76451675 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.74417048 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67716235 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65620116 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64346526 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54440047 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47519738 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45704148 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45342870 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34215507 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33579745 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.33184914 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24113564 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21210274 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.20372350 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.20159899 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19591716 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13063422 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10724414 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07775044 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.04362396 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.00453270 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.00085256 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1964632 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1874173 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1807767 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1753234 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1711471 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1669824 |
| 92 | Leishmaniasis_Homo sapiens_hsa05140 | -0.1640293 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1607735 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1582373 |
| 95 | Lysosome_Homo sapiens_hsa04142 | -0.1495091 |
| 96 | Phagosome_Homo sapiens_hsa04145 | -0.1493593 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1440733 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1346585 |
| 99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1240983 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1158614 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1150267 |
| 102 | Legionellosis_Homo sapiens_hsa05134 | -0.1013872 |
| 103 | Pertussis_Homo sapiens_hsa05133 | -0.0948151 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | -0.0914216 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0675492 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0626807 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0239009 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0081226 |

